Intercept Pharmaceuticals, Inc.

ICPTDelisted Nov 8, 2023

Industry: Pharmaceutical Preparations
SEC CIK: 0001270073

SEC filings (opens in a new tab)

Intercept Pharmaceuticals, Inc. was delisted on Nov 8, 2023; its insiders filed their last Form 4 on Nov 13, 2023; 146 institutions reported holding it in 13F filings for Q3 2023, worth $724.6M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Intercept Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of ICPT: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Q4 2021	Change
Holders	139	147	+8
Shares	22.3M	24.6M	+2.33M (+10.5%)
Value	$331.5M	$401.3M	+$69.8M (+21.0%)

New holders (33)

Institutions that held Intercept Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to ICPT in Q4 2021
Institution	Shares	Value	% of portfolio
Adage Capital Partners GP, L.L.C.	1,233,000	$20.1M	0.04%
Millennium Management LLC	559,678	$9.12M	0.01%
Eventide Asset Management, LLC	327,444	$5.33M	0.07%
HealthInvest Partners AB	183,000	$2.98M	4.20%
Fuller & Thaler Asset Management, Inc.	163,385	$2.66M	0.02%
Acadian Asset Management LLC	126,232	$2.06M	0.01%
Wellington Management Group LLP	95,605	$1.56M	0.00%
Allspring Global Investments Holdings, LLC	88,297	$1.44M	0.00%
Integral Health Asset Management, LLC	75,000	$1.22M	0.34%
Jackson Creek Investment Advisors LLC	59,556	$970.0K	0.35%
Federated Hermes, Inc.	56,198	$915.0K	0.00%
Caxton Associates LP	56,073	$913.0K	0.12%
Lazard Asset Management LLC	42,421	$691.0K	0.00%
Corton Capital Inc.	33,065	$539.0K	0.24%
Putnam Investments LLC	31,400	$511.0K	0.00%
Price T Rowe Associates Inc	27,414	$447.0K	0.00%
PDT Partners, LLC	24,657	$402.0K	0.03%
Boothbay Fund Management, LLC	20,294	$331.0K	0.01%
Group One Trading, L.P.	14,963	$244.0K	0.00%
Hollencrest Capital Management	15,000	$244.0K	0.02%
Winton Group Ltd	13,874	$226.0K	0.01%
Delphia (USA) Inc.	12,830	$209.0K	0.22%
Nomura Holdings Inc	12,691	$207.0K	0.00%
Manteio Capital LLC	12,628	$206.0K	0.27%
Ensign Peak Advisors, Inc	11,070	$180.0K	0.00%
Quantbot Technologies LP	2,568	$41.0K	0.00%
State of Wyoming	2,029	$33.0K	0.02%
FinTrust Capital Advisors, LLC	1,058	$17.0K	0.00%
Signaturefd, LLC	211	$3.00K	0.00%
US Bancorp	56	$1.00K	0.00%
National Bank of Canada	55	$1.00K	0.00%
Glassman Wealth Services	13	$0	0.00%
CoreCap Advisors, LLC	5	–	–

Sold out (25)

Institutions that held Intercept Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of ICPT in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Bank of Montreal	61,455	$959.0K
Duality Advisers, LP	51,196	$760.0K
Los Angeles Capital Management LLC	42,049	$624.0K
SG Americas Securities, LLC	37,988	$564.0K
Trexquant Investment LP	34,839	$517.0K
CWM Advisors, LLC	31,868	$473.0K
First Trust Advisors LP	25,739	$382.0K
Virtus ETF Advisers LLC	21,387	$318.0K
Vontobel Holding Ltd.	15,000	$223.0K
Handelsbanken Fonder AB	13,165	$196.0K
PAX Financial Group, LLC	13,019	$193.0K
Quilter Plc	11,954	$178.0K
Inspire Advisors, LLC	11,494	$171.0K
DekaBank Deutsche Girozentrale	11,090	$167.0K
ProShare Advisors LLC	10,681	$159.0K
SG3 Management, LLC	8,267	$123.0K
Maverick Capital LtdSuperinvestorMaverick Capital	2,827	$42.0K
Franklin Resources Inc	2,417	$36.0K
Point72 Hong Kong Ltd	1,513	$22.0K
Penserra Capital Management LLC	765	$11.0K
Jacobi Capital Management LLC	600	$9.00K
Atlas Private Wealth Advisors	250	$4.00K
Harbour Investments, Inc.	170	$3.00K
Golden State Wealth Management, LLC	100	$1.00K
Captrust Financial Advisors	13	$0